A Prospective, Multicenter, Single-Arm Trial to Evaluate the Safety and Efficacy of the Percutaneous Mechanical Thrombectomy System for Acute Pulmonary Embolism

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070564

Enrollment

Unknown

Registered

2023-04-17

Start date

2021-07-20

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pulmonary embolism

Interventions

Experimental group:the mechanical thrombectomy system

Eligibility

Sex/Gender

All

Age

19 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) 18=age=75 years old, gender is not limited (2) Patients who are clinically diagnosed with acute pulmonary embolism (PE) and need pulmonary artery thrombus removal (3) RV/LV ratio=0.9 (4) Patients who agree to participate in this research and voluntarily sign the informed consent

Exclusion criteria

Exclusion criteria: (1) Target vessel diameter 70 mmHg (5) Hematocrit<28% (6) Patients with a history of chronic pulmonary hypertension (7) Patients with left bundle branch block

Design outcomes

Primary

Measure	Time frame
Change in RV/LV ratio from baseline to 48 hours;Number of Participants With Major Adverse Events;	—

Secondary

Measure	Time frame
Change in PA pressure;	—

Countries

China

Contacts

Public ContactXiaoming Zhang

Peking University People's Hospital

rmyyxgwk@163.com+86 10 8832 4755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026